The global non-invasive cancer diagnosis market is anticipated to grow at a CAGR of 7.2% during the forecast period (2021-2027). The rising prevalence of cancer cases such as breast cancer, lung cancer, blood cancer, among others, increasing awareness for the treatment of cancer, and rising FDA approvals, are driving the non-invasive cancer diagnostics market during the forecast […]
